Patents Assigned to BrainStorm Ceil Therapeutics Ltd.
  • Mesenchymal stem cells for the treatment of CNS diseases
    Patent number: 11185572
    Abstract: An isolated human cell is disclosed comprising at least one mesenchymal stem cell phenotype and secreting brain-derived neurotrophic factor (BDNF), wherein a basal secretion of the BDNF is at least five times greater than a basal secretion of the BDNF in a mesenchymal stem cell. Methods of generating same and uses of same are also disclosed.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: November 30, 2021
    Assignees: Ramot at Tel-Aviv University Ltd., BrainStorm Ceil Therapeutics Ltd.
    Inventors: Avinoam Kadouri, Avihay Bar-Ilan, Eldad Melamed, Daniel Offen, Ofer Sadan, Merav Bahat-Stromza